Skip to main content

CORRECTION article

Front. Endocrinol., 14 July 2023
Sec. Cancer Endocrinology
Volume 14 - 2023 | https://doi.org/10.3389/fendo.2023.1221004

Corrigendum: Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases

This article is a correction to:

  1. Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases

    1. Read original article
Jiahao Xie&#x;Jiahao Xie†Pan Chen&#x;Pan Chen†Jing Wang&#x;Jing Wang†Xiaoqin LuoXiaoqin LuoJiaxin LuoJiaxin LuoXiaoli XiongXiaoli XiongChunyan LiChunyan LiLiqin PanLiqin PanJuqing WuJuqing WuHuijuan FengHuijuan FengWei Ouyang*Wei Ouyang*
  • Department of Nuclear Medicine, The Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China

A Corrigendum on
Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases

by Xie J, Chen P, Wang J, Luo X, Luo J, Xiong X, Li C, Pan L, Wu J, Feng H and Ouyang W (2023) Front. Endocrinol. 14:1094339. doi: 10.3389/fendo.2023.1094339

In the published article, there was an error in Figure 3 as published. The third legend in Figure 3C incorrectly stated “size of the largest metastatic LN>0.4cm”. The corrected Figure 3 and its caption appear below.

In the published article, there was an error. The decimals in Tg cutoff values were incorrect throughout the text. Instead of “10.0”, it should be “10.1”.

The authors apologize for these errors and state that these do not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

FIGURE 3
www.frontiersin.org

Figure 3 (A) The X-tile software of size of the largest metastatic LN for the prediction of persistent/recurrent disease vs long-term remission. (B) Patient frequency according to the size of the largest metastatic LN (the optimal cutoffs were 0.4cm and 1.4cm); (C) Kaplan Meier survival curves for different risk groups (P < 0.001).

Keywords: differentiated thyroid cancer, lymph node metastasis, pre-ablation stimulated Tg, 131I therapy, prognosis

Citation: Xie J, Chen P, Wang J, Luo X, Luo J, Xiong X, Li C, Pan L, Wu J, Feng H and Ouyang W (2023) Corrigendum: Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases. Front. Endocrinol. 14:1221004. doi: 10.3389/fendo.2023.1221004

Received: 11 May 2023; Accepted: 27 June 2023;
Published: 14 July 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Xie, Chen, Wang, Luo, Luo, Xiong, Li, Pan, Wu, Feng and Ouyang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wei Ouyang, b3l3MTk2M0BzaW5hLmNvbQ==

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.